TY - JOUR
T1 - National Heart, Lung, and Blood Institute Clinical Proteomics Working Group Report
AU - Granger, Christopher B.
AU - Van Eyk, Jennifer E.
AU - Mockrin, Stephen C.
AU - Anderson, N. Leigh
PY - 2004/4/13
Y1 - 2004/4/13
N2 - The National Heart, Lung, and Blood Institute (NHLBI) Clinical Proteomics Working Group was charged with identifying opportunities and challenges in clinical proteomics and using these as a basis for recommendations aimed at directly improving patient care. The group included representatives of clinical and translational research, proteomic technologies, laboratory medicine, bioinformatics, and 2 of the NHLBI Proteomics Centers, which form part of a program focused on innovative technology development. This report represents the results from a one-and-a-half-day meeting on May 8 and 9, 2003. For the purposes of this report, clinical proteomics is defined as the systematic, comprehensive, large-scale identification of protein patterns ("fingerprints") of disease and the application of this knowledge to improve patient care and public health through better assessment of disease susceptibility, prevention of disease, selection of therapy for the individual, and monitoring of treatment response.
AB - The National Heart, Lung, and Blood Institute (NHLBI) Clinical Proteomics Working Group was charged with identifying opportunities and challenges in clinical proteomics and using these as a basis for recommendations aimed at directly improving patient care. The group included representatives of clinical and translational research, proteomic technologies, laboratory medicine, bioinformatics, and 2 of the NHLBI Proteomics Centers, which form part of a program focused on innovative technology development. This report represents the results from a one-and-a-half-day meeting on May 8 and 9, 2003. For the purposes of this report, clinical proteomics is defined as the systematic, comprehensive, large-scale identification of protein patterns ("fingerprints") of disease and the application of this knowledge to improve patient care and public health through better assessment of disease susceptibility, prevention of disease, selection of therapy for the individual, and monitoring of treatment response.
KW - Diagnosis
KW - Genetics
KW - Plasma
KW - Prognosis
KW - Proteins
UR - http://www.scopus.com/inward/record.url?scp=4344601818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4344601818&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.0000121563.47232.2A
DO - 10.1161/01.CIR.0000121563.47232.2A
M3 - Review article
C2 - 15078805
AN - SCOPUS:4344601818
SN - 0009-7322
VL - 109
SP - 1697
EP - 1703
JO - Circulation
JF - Circulation
IS - 14
ER -